- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 28.26M sh |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $49.7M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $525.83M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $76.39M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $228.32M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $117.38M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $845.01M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 21.03M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $16.39M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.29 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.29 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $12.84M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$25.12M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $37.23M |